Literature DB >> 21029968

A Flt3L encounter: mTOR signaling in dendritic cells.

Li Wu1.   

Abstract

The signaling pathway of the cytokine Flt3L in dendritic cells (DCs) is poorly defined. In this issue of Immunity, Sathaliyawala et al. (2010) report that the kinase mTOR functions as a mediator of Flt3L signaling in the development and homeostasis of DCs, particularly of the CD8(+) and CD103(+) DCs.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Year:  2010        PMID： 21029968     DOI： 10.1016/j.immuni.2010.10.001

Source DB:  PubMed          Journal:  Immunity        ISSN： 1074-7613            Impact factor:   31.745


  5 in total

Review 1.  New perspectives on mTOR inhibitors (rapamycin, rapalogs and TORKinibs) in transplantation.

Authors:  Matthias Waldner; Daniel Fantus; Mario Solari; Angus W Thomson
Journal:  Br J Clin Pharmacol       Date:  2016-03-06       Impact factor: 4.335

Review 2.  The innate immune response to allotransplants: mechanisms and therapeutic potentials.

Authors:  Jordi Ochando; Farideh Ordikhani; Peter Boros; Stefan Jordan
Journal:  Cell Mol Immunol       Date:  2019-02-25       Impact factor: 11.530

3.  Class I PI3K regulatory subunits control differentiation of dendritic cell subsets and regulate Flt3L mediated signal transduction.

Authors:  Keyur Thummar; Chozha Vendan Rathinam
Journal:  Sci Rep       Date:  2022-07-19       Impact factor: 4.996

4.  SMRT and NCoR1 fine-tune inflammatory versus tolerogenic balance in dendritic cells by differentially regulating STAT3 signaling.

Authors:  Atimukta Jha; Abdul Ahad; Gyan Prakash Mishra; Kaushik Sen; Shuchi Smita; Aliva Prity Minz; Viplov Kumar Biswas; Archana Tripathy; Shantibhushan Senapati; Bhawna Gupta; Hans Acha-Orbea; Sunil Kumar Raghav
Journal:  Front Immunol       Date:  2022-09-27       Impact factor: 8.786

5.  ICOSL+ plasmacytoid dendritic cells as inducer of graft-versus-host disease, responsive to a dual ICOS/CD28 antagonist.

Authors:  Djamilatou Adom; Stacey R Dillon; Jinfeng Yang; Hao Liu; Abdulraouf Ramadan; Kushi Kushekhar; Samantha Hund; Amanda Albright; Maykala Kirksey; Titilayo Adeniyan; Katherine E Lewis; Lawrence Evans; Rebecca Wu; Steven D Levin; Sherri Mudri; Jing Yang; Erika Rickel; Michelle Seaberg; Katherine Henderson; Chelsea J Gudgeon; Martin F Wolfson; Ryan M Swanson; Kristine M Swiderek; Stanford L Peng; Keli L Hippen; Bruce R Blazar; Sophie Paczesny
Journal:  Sci Transl Med       Date:  2020-10-07       Impact factor: 17.956
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.